# Genistein Supplementation Affects Mineral Homeostasis in Rats with Mammary Cancer

## TL;DR

This study shows that genistein supplements, in different forms, change mineral levels in organs of rats with breast cancer.

## Contribution

The novel finding is that genistein supplementation causes significant calcium accumulation in multiple organs of cancer-affected rats.

## Key findings

- Genistein supplementation caused soft tissue calcifications in rats with mammary gland cancer.
- Calcium levels increased significantly in brain, heart, liver, spleen, and femurs of supplemented rats.
- Nanogenistein uniquely caused calcium accumulation in spleen and femurs.

## Abstract

Background: The aim of our study was to analyze the supply of various forms of genistein (nano, micro, and classic) on the content of four macroelements—calcium, magnesium potassium, and sodium—in the kidneys, brains, hearts, livers, spleens and femurs of rats under conditions of mammary gland neoplasia (induced by 7,12-dimethylbenz[a]anthracene (DMBA)). Methods: Thirty-two 30-day-old Sprague-Dawley rats were included in this study. The animals were randomly assigned to four experimental groups: the control group received only a standard diet (without supplementation), while three groups were supplemented with genistein in different forms—nanoparticles (0.1 mg/mL; size 92 ± 41 nm), microparticles (0.1 mg/mL; size 587 ± 83 nm), or macromolecular genistein (0.1 mg/mL). To induce mammary gland cancer, all rats were administered DMBA. Results: In the presented studies, significant changes in the content of elements in the organs of rats supplemented with various forms of genistein were observed. Of particular importance was the occurrence of soft tissue calcifications caused by the dietary supplementation of rats with various forms of genistein, ranging from the classic form to the nanometric form, in the context of an existing mammary gland neoplastic process. Calcium accumulation occurred in various tissues—the brain (from 252% to 449%); the heart (from 159% to 661%); the liver (from 90% to 613%), regardless of the form of genistein; and the spleen (by 127%) and femurs (by 294%) only in the case of nanogenistein supplementation—compared to rats from the control group not supplemented with any form of genistein in conditions of induced mammary gland cancer. Conclusions: Genistein supplementation in cancer conditions affects mineral homeostasis in rats.